| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2016-02-12 | JOHNSON & JOHNSON | ADURO BIOTECH, INC. | 3,906,207 | 6.2% | EDGAR |
| SC 13G/A | 2016-02-10 | BlackRock Inc. | JOHNSON & JOHNSON | 173,844,909 | 6.3% | EDGAR |
| SC 13G/A | 2016-02-10 | VANGUARD GROUP INC | JOHNSON & JOHNSON | 175,393,093 | 6.3% | EDGAR |
| SC 13G | 2015-08-28 | JOHNSON & JOHNSON | CATALYST BIOSCIENCES, INC. | 1,029,144 | 9.0% | EDGAR |
| SC 13G | 2015-07-07 | JOHNSON & JOHNSON | ACHILLION PHARMACEUTICALS INC | 18,367,346 | 15.6% | EDGAR |
| SC 13G | 2015-02-12 | STATE STREET CORP | JOHNSON & JOHNSON | - | 5.7% | EDGAR |
| SC 13G | 2015-02-10 | VANGUARD GROUP INC | JOHNSON & JOHNSON | 163,863,072 | 5.8% | EDGAR |
| SC 13G/A | 2015-02-09 | BlackRock Inc. | JOHNSON & JOHNSON | 171,475,096 | 6.1% | EDGAR |
| SC 13G | 2015-02-06 | JOHNSON & JOHNSON | AQUINOX PHARMACEUTICALS, INC | 1,614,821 | - | EDGAR |
| SC 13G | 2015-02-06 | JOHNSON & JOHNSON | GI DYNAMICS, INC. | 5,655,692 | 6.0% | EDGAR |
| SC 13G | 2015-02-05 | JOHNSON & JOHNSON | GENOCEA BIOSCIENCES, INC. | 1,431,520 | 8.0% | EDGAR |
| SC 13G | 2015-02-05 | JOHNSON & JOHNSON | NEVRO CORP | 3,077,005 | - | EDGAR |
| SC 13G | 2015-02-05 | JOHNSON & JOHNSON | Aldeyra Therapeutics, Inc. | 1,750,292 | - | EDGAR |
| SC 13G | 2015-02-05 | JOHNSON & JOHNSON | MACROGENICS INC | 1,923,077 | 6.5% | EDGAR |
| SC 13G | 2014-07-17 | JOHNSON & JOHNSON | Minerva Neurosciences, Inc. | 3,284,353 | 18.0% | EDGAR |
| SC 13G | 2014-02-03 | STATE STREET CORP | JOHNSON & JOHNSON | - | 5.7% | EDGAR |
| SC 13G/A | 2014-01-29 | BlackRock Inc. | JOHNSON & JOHNSON | 159,666,403 | 5.7% | EDGAR |
| SC 13G/A | 2013-10-10 | JOHNSON & JOHNSON | Prothena Corp plc | 209,421 | 1.0% | EDGAR |
| SC 13G/A | 2013-04-19 | JOHNSON & JOHNSON | ELAN CORP PLC | 25,382,575 | 5.0% | EDGAR |
| SC 13G | 2013-02-13 | JOHNSON & JOHNSON | Prothena Corp plc | 2,619,421 | 14.8% | EDGAR |